Scotland Stevens is a General Partner at OrbiMed Advisors, investing across healthcare, biopharmaceuticals, life sciences, digital health, medical devices, diagnostics, biotechnology, therapeutics, and pharmaceuticals. They invest from early to late stages, including Series A–C and post-IPO. Their geographic scope is global, including North America (United States: New York, California, Massachusetts, New England) and select international markets such as Montréal, Quebec and Lausanne, Vaud. Scotland has invested in companies like Avenzo Therapeutics, CytomX Therapeutics, Verastem Oncology, Q32 Bio, and ReCode Therapeutics. Previously, they were a Public Equity Partner at OrbiMed Advisors and a Vice President at Goldman Sachs. Scotland was educated at The Wharton School and lives in New York.
Scotland Stevens, General Partner @ OrbiMed. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Scotland Stevens from OrbiMed Advisors. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Scotland
Map your path to Scotland instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Scotland
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.